- Aaron Hernandez, ex-Patriot, on prison life: ‘I’m way less stressed in jail’
- Man pulled from water believed to be disgraced D.C. cop
- Kabul airport hit by suicide bomber who targeted NATO gate
- Space probe on course to land on mile-wide comet
- New budget accord saves $23 billion — after $65 billion spending spree
- Congress seeks ban on in-flight calls
- Michelle Malkin’s Twitchy site sold to owners of Townhall, HotAir: report
- GM’s Barra to be first woman to run top American carmaker
- China: Poisonous smog is a military asset, if you think about it
- Texas woman admits to sending ricin to Obama
By Donald Lambro
Growth spikes are little more than trend-free anomalies
Independent voices from the The Washington Times Communities
Topic - Steven Woloshin
Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new study.
That means consumers "may not get the benefit from drugs they think they're getting, or they may expose themselves to more harm than they think" said study co-author Dr. Steven Woloshin of the Dartmouth Institute for Health Policy and Clinical Practice and the VA Outcomes Group.
He and co-author Dr. Lisa Schwartz have been working with the FDA to improve its guidance to drug makers on writing labels, he said.